Subsequently, in-vitro cell experiments confirmed that miR-29c-3p targeted SERPINH1, thereby repressing angiogenesis and inactivating the Wnt signaling pathway in ESCC cells. This evidence concerns the gene SERPINH1 and esophageal squamous cell carcinoma.